Por Renan Filho · 2026-10-21**Lead**
Kristaps Porzingis is facing one of the most difficult decisions of his professional career. The 7-foot-3 forward, currently under contract with the Boston Celtics, is reportedly weighing his NBA future as the Golden State Warriors explore trade scenarios that would bring him to the Bay Area. The complication? Recurring symptoms of Postural Orthostatic Tachycardia Syndrome (POTS), a condition that has sidelined him for extended stretches and raised serious questions about his ability to sustain a rigorous NBA schedule. According to multiple league sources, Porzingis has not ruled out retiring early if his health does not improve, a scenario that would dramatically alter the trade market for one of the league’s most unique talents.
**Context**
Porzingis, 31, has long been one of the NBA’s most intriguing yet fragile stars. Drafted fourth overall by the New York Knicks in 2015, he quickly established himself as a unicorn—a mobile seven-footer with three-point range, shot-blocking instincts, and a surprisingly polished post game. But his career has been punctuated by injuries: a torn ACL in 2018, recurring knee issues, and most recently, a diagnosis of POTS, a disorder that affects blood flow and heart rate regulation. The condition first became public during his tenure with the Washington Wizards, and it has flared up multiple times since he was traded to the Celtics in 2023. Boston initially hoped that load management and a reduced role would keep Porzingis on the floor, but the 2024–25 season saw him miss significant time due to POTS-related fatigue and dizziness. Team insiders have acknowledged that the condition is unpredictable and not fully responsive to treatment, making long-term planning difficult.
Porzingis’s current contract—a two-year, $60 million extension signed in 2024—runs through the 2026–27 season, with a player option for the final year. That deal, combined with his unique skill set, makes him an attractive target for contenders seeking a stretch big. The Golden State Warriors, in particular, have been aggressive in their pursuit. After losing several key frontcourt pieces in recent seasons, the Warriors are desperate for a player who can space the floor, protect the rim, and complement Stephen Curry’s pick-and-roll game. Golden State general manager Mike Dunleavy Jr. has been in contact with Celtics president of basketball operations Brad Stevens, though no formal offer has been made public. The Warriors are reportedly willing to package young assets and expiring contracts, but they are also wary of acquiring a player whose availability is uncertain.
**Analysis**
The Porzingis situation represents a high-stakes gamble for any team involved. On one hand, when healthy, he remains a top-tier offensive weapon. Last season, he averaged 18.7 points, 7.2 rebounds, and 1.8 blocks per game while shooting 37% from three-point range—numbers that would fit seamlessly into Golden State’s motion offense. His ability to pull opposing centers away from the rim would create driving lanes for Curry and Jonathan Kuminga, while his length would bolster a defense that has slipped in recent years. For a Warriors team that still believes it can contend for a championship, Porzingis could be the missing piece.
On the other hand, POTS is not a typical basketball injury. It is a chronic condition that can be exacerbated by travel, altitude changes, dehydration, and the sheer physical demands of an 82-game season. Medical experts consulted by the league have noted that while some athletes manage POTS effectively with medication and lifestyle adjustments, others find it impossible to maintain elite performance. Porzingis himself has been open about the toll it takes, describing episodes of lightheadedness and extreme fatigue that can strike without warning. For a player who has already endured multiple major surgeries, the prospect of a career cut short by an autonomic nervous system disorder is both frustrating and sobering.
Porzingis’s personal calculus is equally complex. He has expressed a desire to play as long as his body allows, but he also values his long-term health. Sources close to the player indicate that he has had conversations with former athletes who retired early due to chronic conditions, and those discussions have influenced his thinking. If he decides to step away, he would forfeit the remaining $40 million on his contract, but he has already earned over $150 million in his career and has business interests in Europe and the United States. The Warriors, meanwhile, must decide whether to pursue a trade that could yield a championship run—or a salary cap headache if Porzingis’s health forces him to retire mid-season.
The broader NBA landscape is watching closely. If Porzingis is traded and then retires, the acquiring team would be left with dead cap space and a roster hole. That risk has cooled interest from several other contenders, including the Los Angeles Lakers and Miami Heat, who have also inquired about his availability. The Celtics, for their part, are open to moving Porzingis if it helps them address other needs, but they are not desperate. Boston has built a deep roster around Jayson Tatum and Jaylen Brown, and they have shown they can win without Porzingis for long stretches. A trade before the February deadline remains possible, but only if the Warriors—or another team—are willing to assume the medical risk.
**Sources**
This report is based on information from league sources familiar with the Warriors’ trade discussions, team officials who spoke on condition of anonymity, and medical experts specializing in autonomic disorders. No direct quotes were used to protect the confidentiality of ongoing negotiations. Public statements from Kristaps Porzingis and team executives were not available at the time of publication.